GleamWall
中文EN

IPSC Century Therapeutics, Inc.

Biological Products, (No Diagnostic Substances) · Nasdaq · SEC CIK 1850119 · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (2025Q4), TTM = sum of the last four quarters

Growth

TTM revenue YoY1,556.5%
TTM net income YoY92.4%
TTM EPS YoY91.3%
Revenue 3-yr CAGR175.9%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-15.8%
Net margin-8.8%
FCF margin-95.9%
EBITDA margin-3.8%

Returns

ROE-6.0%
ROA-3.3%
ROIC (approx.)-13.8%
Asset turnover0.38x

Leverage & solvency

Liabilities / assets29.0%
Debt / equity0.00x
Current ratio5.97x
Interest coverage—

Cash quality & payout

Operating cash flow / net income10.85x
Accruals ratio32.7%
Payout ratio—
Capex / revenue0.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$109.16M$6.59M
R&D expense$95.67M$107.24M
SG&A expense$24.00M$33.16M
Operating income-$17.27M-$138.14M
Pretax income-$9.65M-$124.78M
Income tax-$68,000$1.79M
Net income-$9.58M-$126.57M
EBITDA-$4.17M-$124.83M
EPS (basic)-0.14-1.61
EPS (diluted)-0.14-1.61
Weighted avg. shares (diluted)86.56M78.65M
Balance sheet
Cash & equivalents$61.85M$61.21M
Short-term investments$55.26M$130.85M
Current assets$120.77M$194.05M
PP&E, net$50.03M$62.14M
Intangibles$34.20M$34.20M
Total assets$223.70M$353.22M
Current liabilities$20.23M$129.78M
Total liabilities$64.77M$191.85M
Shareholders' equity$158.94M$161.36M
Shares outstanding87.52M85.84M
Cash flow statement
Operating cash flow-$103.88M-$110.14M
Capital expenditure$848,000$154,000
Free cash flow-$104.72M-$110.29M
Investing cash flow$107.50M$47.48M
Financing cash flow$173,000$74.56M
Depreciation & amortization$13.10M$13.30M
Stock-based compensation$6.84M$12.69M

Free plan shows the latest 2 periods; Pro shows all 6 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.